EP4070800
Kladribín-meðferðaráform til meðhöndlunar á heila- og mænusiggi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.12.2005EP published:
16.10.2024EP application number:
22166610.0
EP translation filed:
18.12.2024Grant published:
15.1.2025EPO information:
European Patent Register
Max expiry date:
19.12.2025Expiry date:
19.12.2025
Title in English:
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSISLanguage of the patent:
English
Timeline
Today
20.12.2005EP application
16.10.2024EP Publication
18.12.2024Translation submitted
15.1.2025Registration published
19.12.2025Expires
Owner
Name:
Merck Serono S.A.Address:
Route de la Verrerie 6 Zone Industrielle, 1267 Coinsins, CH
Inventor
Name:
De Luca, GiampieroAddress:
1267 Coinsins, CH
Name:
Ythier, ArnaudAddress:
1267 Coinsins, CH
Name:
Munafo, AlainAddress:
1267 Coinsins, CH
Name:
Lopez-Bresnahan, MariaAddress:
1267 Coinsins, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
638669 PDate:
22.12.2004Country:
US
Number:
04106909Date:
22.12.2004Country:
EP
Classification
Categories:
A61K 31/7076, A61K 38/21, A61P 25/00, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 20
Paid: 28.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.